Yunfeng Capital and Alibaba Acquisition of iKang Healthcare

Davis Polk is advising iKang Healthcare Group, Inc. in connection with its acquisition for $41.20 per common share or $20.60 per American Depository Share by a consortium consisting of certain funds affiliated with Yunfeng Capital, Alibaba Group Holding Limited and certain of iKang’s senior management.

The transaction is subject to customary closing conditions, including approval by the shareholders of iKang and is expected to close in the third quarter of 2018.

Headquartered in Beijing, China, and listed on Nasdaq, iKang is one of the largest providers in China’s fast-growing private preventive health care service market through its nationwide health care services network. iKang’s nationwide integrated network of multi-brand self-owned medical centers and third-party facilities, provides comprehensive and high-quality preventive health care solutions across China, including medical examination, disease screening, dental service and other value-added services. The company, led by Ligang Zhang, Boquan He and Yang Chen, in 2017 recorede $435 Million Revenues.

The Davis Polk corporate team includes partners Howard Zhang (Picture) and Li He, and registered foreign lawyer Xiaotong (Lisa) Yuan.

Involved fees earner: Howard Zhang – Davis Polk & Wardwell; Li He – Davis Polk & Wardwell; Xiaotong Yuan – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: iKang Healthcare Group, Inc.;

Print Friendly, PDF & Email

Author: Michael Patrini